CCA
BDSX icon

Conestoga Capital Advisors’s Biodesix BDSX Stock Holding History

Conestoga Capital Advisors’s Portfolio BDSX Stock Details BDSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-5,756
Closed -$946K – 145
2021
Q3 		$946K Buy
5,756
+5
+0.1% +$948 0.01% 105
2021
Q2 		$1.52M Buy
5,751
+968
+20% +$304K 0.02% 91
2021
Q1 		$1.94M Buy
4,783
+938
+24% +$419K 0.03% 80
2020
Q4 		$1.55M Buy
+3,845
New +$1.2M 0.02% 84

Other funds holding BDSX

BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PGM
Parian Global Management Pound Ridge, New York $30.8M AUM 51.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Conestoga Capital Advisors's BDSX Position: Q4 2021 in Review

Conestoga Capital Advisors sold out of Biodesix (BDSX) in Q4 2021, closing a stake of 5,756 shares — an estimated $946K sold.

Conestoga Capital Advisors first reported a position in BDSX in Q4 2020 and held it in 4 quarters. The position peaked at $1.94M in Q1 2021. 41 funds tracked by Wall St. Rank hold BDSX as of Q4 2021.

  • Conestoga Capital Advisors reported no remaining Biodesix position as of Q4 2021 after selling out during the quarter.
  • Conestoga Capital Advisors sold 5,756 Biodesix shares in Q4 2021, an estimated $946K.
  • Conestoga Capital Advisors first reported a position in Biodesix in Q4 2020 and held it in 4 quarters.
  • Conestoga Capital Advisors's Biodesix position peaked at $1.94M in Q1 2021.
  • 41 funds tracked by Wall St. Rank held Biodesix as of Q4 2021.

Based on Conestoga Capital Advisors's 13F filing for Q4 2021, filed 21 Jan 2022.